Skip to main content

Table 1 Clinical data for MS patients: a -- active MS; RR -- relapsing-remitting; F -- female; M -- male.

From: B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity

MS patient

MS type

Age (years)

Gender

MS patient

MS type

Age (years)

Gender

1

RR a

28

M

24

RR

56

F

2

RR a

70

F

25

RR

59

F

3

RR a

34

F

26

RR

63

F

4

RR a

40

F

27

RR

50

F

5

RR a

53

F

28

RR

65

M

6

RR a

62

M

29

RR

55

M

7

RR a

35

M

30

RR

29

F

8

RR a

56

F

31

RR

63

F

9

RR a

37

F

32

RR

31

M

10

RR a

53

M

33

RR

58

M

11

RR a

30

M

34

RR

23

M

12

RR a

38

F

35

RR

43

M

13

RR a

60

F

36

RR

58

F

14

RR a

54

F

37

RR

66

M

15

RR a

30

F

38

RR

57

F

16

RR a

51

F

39

RR

35

M

17

RR a

53

F

40

RR

39

F

18

RR a

53

F

41

RR

83

F

19

RR a

58

F

42

RR

56

F

20

RR a

51

F

43

RR

40

F

21

RR a

49

F

44

RR

26

F

22

RR a

44

F

45

RR

28

F

23

RR a

60

F

46

RR

43

M